News archive.
Earlier AI news and analysis, kept for reference. Current coverage lives in News & Analysis.
Duckweed cuts antibody production costs 80%, targeting $300B patent cliff
Phylloceuticals' Lemna-based system produces monoclonal antibodies in 16 weeks instead of 12+ months, with near-zero genetic drift. The startup is positioning itself as a biosimilar manufacturer's cost hedge.
Single Brain Probe Records and Controls Neurons Simultaneously
Neuropixels Opto combines 960 recording sites and light emitters on a thin probe to measure neural activity and optogenetically stimulate neurons at the same time. Neuroscientists can now test which neurons actually drive behavior.
Gout drugs dotinurad and pozdeutinurad compete for 1.5M US patients failing allopurinol
Crystalys dosed the first patient in a Phase II gout trial as rival Sobi reported 69% efficacy with pozdeutinurad. Both target the same market: people intolerant to or unresponsive to the standard treatment.
Pharma pools proprietary data to train AI models without sharing secrets
Eli Lilly's federated learning platform now has 75+ biotech partners across three continents. Here's why training AI on encrypted data matters for drug discovery.
India's Med Schools Get 10 Years to Finish MBBS Again
India's medical regulator proposes returning to a 10-year completion window for MBBS students, up from nine years set in 2023. The rule would let struggling students finish without losing eligibility.
India's Supreme Court blocks computer-based NEET re-exam
The Supreme Court rejected a plea to shift the June 21 NEET re-test to computer-based format, citing operational difficulties. The exam will stay pen-and-paper despite calls for systemic reform.
Two autism subtypes identified in study of 940 children and mice
Researchers found one autism subtype linked to immune dysfunction, another to synaptic problems. The discovery could guide personalized diagnosis and treatment for about 25% of cases studied.
India detects no Ebola cases; urges 21-day watch for African travellers
India's Health Ministry issued an Ebola advisory on June 2 after fresh outbreaks in Africa. No cases confirmed in-country yet, but anyone transiting affected regions in the past 21 days should monitor for fever, bleeding, and report immediately.
Rural rape survivors can now access expert forensic care by video
A nurse-led telehealth platform connects rural hospitals with certified sexual assault examiners in real time. 24 partner hospitals across two states have seen care-seeking increase 25–280% in year one.
Rural healthcare pilots need evidence, not AI optimism
Healthcare leaders gathered at HIMSS26 APAC and AI in Healthcare Forum to confront a gap: rural care deployments demand real-world proof, not vendor roadmaps. What works and what doesn't.
Orphan drugs hold ground despite market turbulence in 2026
Orphan drug makers are sustaining commercial momentum and pipeline strength through a volatile year. Insights from the 2026 report show why rare-disease programs remain strategically valuable.
Servier pays up to $2.7B for muscular dystrophy drug from Edgewise
French pharmaceutical company Servier has agreed to acquire an experimental tablet from Edgewise Therapeutics for a deal potentially worth $2.7 billion. Analysts project peak sales above $2 billion if the drug succeeds in late-stage trials.